ICE CREAM: Irinotecan cetuximab evaluation and the cetuximab response evaluation among patients with G13D mutation
Version 2 2024-06-19, 00:51Version 2 2024-06-19, 00:51
Version 1 2022-11-25, 02:52Version 1 2022-11-25, 02:52
conference contribution
posted on 2024-06-19, 00:51authored byEva Segelov, Kate Wilson, Val Gebski, Paul Michael Waring, Josep Tabernero, Harpreet Wasan, Fortunato Ciardiello, Jayesh Desai, Craig Underhill, Christos Stelios Karapetis, Mustafa Khasraw, Louise A Nott, Warren Lance Joubert, Nick Pavlakis, Guy Van Hazel, Lorraine A Chantrill, Timothy Jay Price, Michael Jefford, Andrew Mark Haydon, Jeremy David Shapiro
ICE CREAM: Irinotecan cetuximab evaluation and the cetuximab response evaluation among patients with G13D mutation